$0.1154
0.00373.31%
Last update: Aug 20, 1:13 PM
Liminatus Pharma Inc (LIMN) Stock Price, Quote, News & History
LIMNNASDAQ
PRO
Stock Split: Liminatus Pharma Inc is expected to split
Friday, August 21, 2026 with a ratio of
1:50
Earnings: Q2 2026 Earnings were released on Fri Aug 14th, after the market close
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Liminatus Pharma (LIMN) stock?
You can purchase shares of Liminatus Pharma (NASDAQ:LIMN) through any online brokerage.
Who are Liminatus Pharma (LIMN) competitors?
Other companies in Liminatus Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Liminatus Pharma (LIMN) stock?
There is no analysis for Liminatus Pharma to provide a consensus price target.
What is the current price for Liminatus Pharma (LIMN)?
The stock price for Liminatus Pharma (NASDAQ: LIMN) is $0.1154 last updated August 20, 2026 at 1:13 PM EDT.
Does Liminatus Pharma (LIMN) pay a dividend?
There are no upcoming dividends for Liminatus Pharma.
When is Liminatus Pharma (NASDAQ:LIMN) reporting earnings?
Liminatus Pharma does not have any upcoming earnings scheduled.
Is Liminatus Pharma (LIMN) going to split?
There is no upcoming split for Liminatus Pharma.
What sector and industry does Liminatus Pharma (LIMN) operate in?
Liminatus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
